Related Experiment Video
Updated: Oct 1, 2025
06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
10.8K
Advances in computer-aided drug design for type 2 diabetes
Wanqiu Huang1,2,3, Luyong Zhang1,2,3,4, Zheng Li1,2
1School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, PR China.
Expert Opinion on Drug Discovery
|March 7, 2022
Summary
Computer-aided drug design (CADD) accelerates the discovery of novel anti-diabetic agents by targeting key proteins. Despite challenges, AI and advanced modeling like AlphaFold promise further advancements in developing new diabetes treatments.
Area of Science:
- Pharmacology
- Computational Chemistry
- Drug Discovery
Background:
- Rising global diabetes prevalence creates a significant socioeconomic burden.
- Traditional drug development is slow and expensive, necessitating innovative approaches.
- Computer-aided drug design (CADD) offers a transformative solution for efficient drug discovery.
Purpose of the Study:
- To review the application of CADD in designing drugs for diabetes.
- To highlight CADD's role in discovering novel anti-diabetic agents.
- To discuss future directions and emerging technologies in CADD for diabetes.
Main Methods:
- Review of CADD strategies applied to diabetic drug discovery.
- Elaboration on specific anti-diabetic targets including PPAR, GPR40, DDP-IV, PTP1B, SGLT-2, and GK.
- Analysis of CADD's contribution to identifying drug candidates for these targets.
Main Results:
- CADD has significantly contributed to identifying novel anti-diabetic drug candidates.
- Specific CADD strategies are linked to the discovery of drugs targeting key diabetes-related proteins.
- The review covers advancements in CADD for various diabetes targets.
Conclusions:
- CADD has proven effective in discovering new anti-diabetic medications.
- Limitations in CADD include challenges with co-crystal structures and dynamic simulations.
- Artificial intelligence (AI) and AlphaFold are poised to accelerate future drug discovery and reduce costs.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
3.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.1K
01:15Diabetes: Management and Pharmacotherapy
427
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
427
01:28Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
01:36Carbohydrate Metabolism
12.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.1K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
327
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
327
01:22Diabetes Mellitus: Overview and Type I Subtype
3.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.4K